Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cally Roper

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
International Journal for Parasitology|December 21, 2017
A reference genome and methylome for the Plasmodium knowlesi A1-H.1 lineErnest Diez Benavente, Paola Florez de Sessions, Robert W Moon, et al.
The American Journal of Tropical Medicine and Hygiene|July 16, 2021
Identification of Single-Nucleotide Polymorphisms in the Mitochondrial Genome and Kelch 13 Gene of Plasmodium falciparum in Different Geographical PopulationsTine Kliim Nydahl, Samuel Yao Ahorhorlu, Magatte Ndiaye, et al.
Plos One|February 25, 2009
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581Samwel Gesase, Roly D Gosling, Ramadhan Hashim, et al.
Plos One|November 9, 2013
Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countriesMyriam Gharbi, Jennifer A Flegg, Bruno Pradines, et al.
Emerging Infectious Diseases|July 26, 2014
Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and EthiopiaMichael Alifrangis, Sidsel Nag, Mette L Schousboe, et al.
Malaria Journal|December 1, 2016
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in MalawiMatt Ravenhall, Ernest Diez Benavente, Mwapatsa Mipando, et al.
Malaria Journal|January 29, 2010
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapyWilfred F Mbacham, Marie-Solange B Evehe, Palmer M Netongo, et al.
BMC Infectious Diseases|September 26, 2024
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in CameroonRosario Martinez-Vega, Wilfred Fon Mbacham, Innocent Ali, et al.
Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malariaChristopher V Plowe, Cally Roper, John W Barnwell, et al.
Scientific Reports|October 20, 2018
Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine developmentErnest Diez Benavente, Damilola R Oresegun, Paola Florez de Sessions, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
International Journal for Parasitology|December 21, 2017
A reference genome and methylome for the Plasmodium knowlesi A1-H.1 lineErnest Diez Benavente, Paola Florez de Sessions, Robert W Moon, et al.
The American Journal of Tropical Medicine and Hygiene|July 16, 2021
Identification of Single-Nucleotide Polymorphisms in the Mitochondrial Genome and Kelch 13 Gene of Plasmodium falciparum in Different Geographical PopulationsTine Kliim Nydahl, Samuel Yao Ahorhorlu, Magatte Ndiaye, et al.
Plos One|February 25, 2009
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581Samwel Gesase, Roly D Gosling, Ramadhan Hashim, et al.
Plos One|November 9, 2013
Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countriesMyriam Gharbi, Jennifer A Flegg, Bruno Pradines, et al.
Emerging Infectious Diseases|July 26, 2014
Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and EthiopiaMichael Alifrangis, Sidsel Nag, Mette L Schousboe, et al.
Malaria Journal|December 1, 2016
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in MalawiMatt Ravenhall, Ernest Diez Benavente, Mwapatsa Mipando, et al.
Malaria Journal|January 29, 2010
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapyWilfred F Mbacham, Marie-Solange B Evehe, Palmer M Netongo, et al.
BMC Infectious Diseases|September 26, 2024
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in CameroonRosario Martinez-Vega, Wilfred Fon Mbacham, Innocent Ali, et al.
Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malariaChristopher V Plowe, Cally Roper, John W Barnwell, et al.
Scientific Reports|October 20, 2018
Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine developmentErnest Diez Benavente, Damilola R Oresegun, Paola Florez de Sessions, et al.
Pageof 9